Clinical Trials · NCT00937768
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Mayo Clinic
- Enrollment
- 16
- Start date
- Jul 2009
- Locations
- 1 site, United States
- Primary endpoint
- Biochemical Progression-free Survival Rate